Targeting Alternative Splicing as Adjunctive Treatment in EML4-ALK v3a/b+ NSCLC: Knowing Our Socratic Paradox and Learning From Spinal Muscular Atrophy

doi:10.1016/j.jtho.2021.11.010

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Targeting Alternative Splicing as Adjunctive Treatment in EML4-ALK v3a/b+ NSCLC: Knowing Our Socratic Paradox and Learning From Spinal Muscular Atrophy

21 Jan 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic factors in colorectal cancer
Share to Genomics and Rare Diseases
Share to Lung Cancer Treatments and Mutations

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Open in PubMed

Identifiers

PMID: 35074224
DOI: 10.1016/j.jtho.2021.11.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Targeting Alternative Splicing as Adjunctive Treatment in EML4-ALK v3a/b+ NSCLC: Knowing Our Socratic Paradox and Learning From Spinal Muscular AtrophyPMID 35074224Read ↗

Oligoprogressive Disease With SCLC Transformation in EGFR-Mutated NSCLC: How Biology Knowledge Can Change the Game RulesSemantic proximity Read ↗

From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to TranslationSemantic proximity Read ↗

mRNA splicing variants: exploiting modularity to outwit cancer therapy.Semantic proximity Read ↗

Alternative splicing dysregulation across tissue and therapeutic approaches in a mouse model of myotonic dystrophy type 1Semantic proximity Read ↗

Alternative Splicing of ALS Genes: Misregulation and Potential TherapiesSemantic proximity Read ↗

Alternative splicing and cancer: insights, opportunities, and challenges from an expanding view of the transcriptome.Semantic proximity Read ↗

Roles and mechanisms of alternative splicing in cancer - implications for care.Semantic proximity Read ↗

The role of alternative splicing in cancer: From oncogenesis to drug resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.